Soft tissue sarcomas of the upper extremities: Maximizing treatment opportunities and outcomes (Review)
- Authors:
- Jose Duran‑Moreno
- Vasileios Kontogeorgakos
- Anna Koumarianou
-
Affiliations: Hematology Oncology Unit, Fourth Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, ‘Attikon’ University General Hospital, Athens 12462, Greece, Department of Orthopaedic Surgery, National and Kapodistrian University of Athens, ‘Attikon’ University General Hospital, Athens 12462, Greece - Published online on: July 5, 2019 https://doi.org/10.3892/ol.2019.10575
- Pages: 2179-2191
-
Copyright: © Duran‑Moreno et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Stiller CA, Trama A, Serraino D, Rossi S, Navarro C, Chirlaque MD and Casali PG; RARECARE Working Group, : Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project. Eur J Cancer. 49:684–695. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Burningham Z, Hashibe M, Spector L and Schiffman JD: The epidemiology of Sarcoma. Clin Sarcoma Res. 2:142012. View Article : Google Scholar : PubMed/NCBI | |
|
Gustafson P and Arner M: Soft tissue sarcoma of the upper extremity: Descriptive data and outcome in a population-based series of 108 adult patients. J Hand Surg Am. 24:668–674. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Gerrand CH, Wunder JS, Kandel RA, O'Sullivan B, Catton CN, Bell RS, Bell RS, Griffin AM and Davis AM: The influence of anatomic location on functional outcome in lower-extremity soft-tissue sarcoma. Ann Surg Oncol. 11:476–482. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Müller DA, Beltrami G, Scoccianti G, Frenos F and Capanna R: Combining limb-sparing surgery with radiation therapy in high-grade soft tissue sarcoma of extremities-is it effective? Eur J Surg Oncol. 42:1057–1063. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Fletcher CDM, Unni KK and Mertens F: World Health Organization Classification of Tumours. Pathology and genetics of tumours of soft tissue and bone, IARC Press. pp. Lyon2002 | |
|
Lazerges C: Soft tissue sarcomas of the forearm, wrist and hand. Hand Surg Rehabil. 36:233–243. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Strauss DC, Qureshi YA, Hayes AJ, Thway K, Fisher C and Thomas JM: The role of core needle biopsy in the diagnosis of suspected soft tissue tumours. J Surg Oncol. 102:523–529. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Korah MP, Deyrup AT, Monson DK, Oskouei SV, Weiss SW, Landry J and Godette KD: Anatomic tumor location influences the success of contemporary limb-sparing surgery and radiation among adults with soft tissue sarcomas of the extremities. Int J Radiat Oncol Biol Phys. 82:933–939. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Dailiana ZH, Bougioukli S, Varitimidis S, Kontogeorgakos V, Togia E, Vlychou M and Malizos KN: Tumors and tumor-like lesions mimicking carpal tunnel syndrome. Arch Orthop Trauma Surg. 134:139–144. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Nandra R, Forsberg J and Grimer R: If your lump is bigger than a golf ball and growing, think Sarcoma. Eur J Surg Oncol. 41:1400–1405. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Callister MD, Ballo MT, Pisters PW, Patel SR, Feig BW, Pollock RE, Benjamin RS and Zagars GK: Epithelioid sarcoma: Results of conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 51:384–391. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Kawai A, Hosono A, Nakayama R, Matsumine A, Matsumoto S, Ueda T, Tsuchiya H, Beppu Y, Morioka H and Yabe H; Japanese Musculoskeletal Oncology Group, : Clear cell sarcoma of tendons and aponeuroses: A study of 75 patients. Cancer. 109:109–116. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Walker EA, Salesky JS, Fenton ME and Murphey MD: Magnetic resonance imaging of malignant soft tissue neoplasms in the adult. Radiol Clin North Am. 491219–1234. (vi)2011. View Article : Google Scholar : PubMed/NCBI | |
|
Kransdorf MJ, Bancroft LW, Peterson JJ, Murphey MD, Foster WC and Temple HT: Imaging of fatty tumors: Distinction of lipoma and well-differentiated liposarcoma. Radiology. 224:99–104. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Vasileios KA, Eward WC and Brigman BE: Surgical treatment and prognosis in patients with high-grade soft tissue malignant fibrous histiocytoma of the extremities. Arch Orthop Trauma Surg. 132:955–961. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Heslin MJ, Lewis JJ, Woodruff JM and Brennan MF: Core needle biopsy for diagnosis of extremity soft tissue sarcoma. Ann Surg Oncol. 4:425–431. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Errani C, Traina F, Perna F, Calamelli C and Faldini C: Current concepts in the biopsy of musculoskeletal tumors. ScientificWorldJournal. 013:5381522013. | |
|
Khoo M, Pressney I, Hargunani R and Saifuddin A: Small, superficial, indeterminate soft-tissue lesions as suspected sarcomas: Is primary excision biopsy suitable? Skeletal Radiol. 46:919–924. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
van der Heijden L, Gibbons CL, Hassan AB, Kroep JR, Gelderblom H, van Rijswijk CS, Nout RA, Bradley KM, Athanasou NA, Dijkstra PD, et al: A multidisciplinary approach to giant cell tumors of tendon sheath and synovium-a critical appraisal of literature and treatment proposal. J Surg Oncol. 107:433–445. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Giuliano AE and Eilber FR: The rationale for planned reoperation after unplanned total excision of soft-tissue sarcomas. J Clin Oncol. 3:1344–1348. 1985. View Article : Google Scholar : PubMed/NCBI | |
|
Puhaindran ME, Rothrock CP and Athanasian EA: Surgical management for malignant tumors of the thumb. Hand (NY). 6:373–377. 2011. View Article : Google Scholar | |
|
Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, et al: Soft tissue and visceral sarcomas: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 29 (Suppl 4):iv268–iv269. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Serpell JW, Ball AB, Robinson MH, Fryatt I, Fisher C and Thomas JM: Factors influencing local recurrence and survival in patients with soft tissue sarcoma of the upper limb. Br J Surg. 78:1368–1372. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Lin PP, Guzel VB, Pisters PWT, Zagars GK, Weber KL, Feig BW, Pollock RE and Yasko AW: Surgical management of soft tissue sarcomas of the hand and foot. Cancer. 95:852–861. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Perloff M and Holland JF: Surgical adjuvant chemotherapy. Annu Rev Med. 28:475–488. 1977. View Article : Google Scholar : PubMed/NCBI | |
|
Rosenberg SA, Kent H, Costa J, Webber BL, Young R, Chabner B, Baker AR, Brennan MF, Chretien PB, Cohen MH, et al: Prospective randomized evaluation of the role of limb-sparing surgery, radiation therapy, and adjuvant chemoimmunotherapy in the treatment of adult soft-tissue sarcomas. Surgery. 84:62–69. 1978.PubMed/NCBI | |
|
Alamanda VK, Crosby SN, Archer KR, Song Y, Schwartz HS and Holt GE: Amputation for extremity soft tissue sarcoma does not increase overall survival: A retrospective cohort study. Eur J Surg Oncol. 38:1178–1183. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Blay JY, Soibinet P, Penel N, Bompas E, Duffaud F, Stoeckle E, Mir O, Adam J, Chevreau C, Bonvalot S, et al: Improved survival using specialized multidisciplinary board in sarcoma patients. Ann Oncol. 28:2852–2859. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Cantin J, McNeer GP, Chu FC and Booher RJ: The problem of local recurrence after treatment of soft tissue sarcoma. Ann Surg. 168:47–53. 1968. View Article : Google Scholar : PubMed/NCBI | |
|
Enneking WF, Spanier SS and Goodman MA: A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res. 106–120. 1980.PubMed/NCBI | |
|
Harati K, Goertz O, Pieper A, Daigeler A, Joneidi-Jafari H, Niggemann H, Stricker I and Lehnhardt M: Soft Tissue sarcomas of the extremities: Surgical margins can be close as long as the resected tumor has no ink on it. Oncologist. 22:1400–1410. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Pradhan A, Cheung YC, Grimer RJ, Peake D, Al-Muderis OA, Thomas JM and Smith M: Soft-tissue sarcomas of the hand: Oncological outcome and prognostic factors. J Bone Joint Surg Br. 90:209–214. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Puhaindran ME, Healey JH and Athanasian EA: Single ray amputation for tumors of the hand. Clin Orthop Relat Res. 468:1390–1395. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Puhaindran ME and Athanasian EA: Double ray amputation for tumors of the hand. Clin Orthop Relat Res. 468:2976–2979. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Tsukushi S, Nishida Y, Urakawa H, Arai E, Kozawa E and Ishiguro N: Planned preservation surgery for soft tissue sarcomas adjacent to critical structures. Arch Orthop Trauma Surg. 133:481–486. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Clarkson PW, Griffin AM, Cotton CN, O'Sullivan B, Ferguson PC, Wunder JS and Bell RS: Epineural dissection is a safe technique that facilitates limb salvage surgery. Clin Orthop Relat Res. 438:92–96. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Radaelli S, Fiore M, Colombo C, Ford S, Palassini E, Sanfilippo R, Stacchiotti S, Sangalli C, Morosi C, Casali PG and Gronchi A: Vascular resection en-bloc with tumor removal and graft reconstruction is safe and effective in soft tissue sarcoma (STS) of the extremities and retroperitoneum. Surg Oncol. 25:125–131. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Elias DA, White LM, Simpson DJ, Kandel RA, Tomlinson G, Bell RS and Wunder JS: Osseous invasion by soft-tissue sarcoma: Assessment with MR imaging. Radiology. 229:145–152. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Ferguson PC, Griffin AM, O'Sullivan B, Catton CN, Davis AM, Murji A, Bell RS and Wunder JS: Bone invasion in extremity soft-tissue sarcoma: Impact on disease outcomes. Cancer. 106:2692–2700. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Lin PP, Pino ED, Normand AN, Deavers MT, Cannon CP, Ballo MT, Pisters PW, Pollock RE, Lewis VO, Zagars GK and Yasko AW: Periosteal margin in soft-tissue sarcoma. Cancer. 109:598–602. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Megerle K and Sauerbier M: Reconstructive treatment of soft tissue sarcoma of the upper extremity. J Hand Surg Am. 36:1241–1247. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Tseng JF, Ballo MT, Langstein HN, Wayne JD, Cormier JN, Hunt KK, Feig BW, Yasko AW, Lewis VO, Lin PP, et al: The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas. Ann Surg Oncol. 13:1209–1215. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Weitz J, Antonescu CR and Brennan MF: Localized extremity soft tissue sarcoma: Improved knowledge with unchanged survival over time. J Clin Oncol. 21:2719–2725. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Stojadinovic A, Leung DHY, Allen P, Lewis JJ, Jaques DP and Brennan MF: Primary adult soft tissue sarcoma: Time-dependent influence of prognostic variables. J Clin Oncol. 20:4344–4352. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Italiano A, Delva F, Mathoulin-Pelissier S, Le Cesne A, Bonvalot S, Terrier P, Trassard M, Michels JJ, Blay JY, Coindre JM and Bui B: Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: A multivariate analysis of the French sarcoma group database. Ann Oncol. 21:2436–2441. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Gronchi A, Casali PG, Mariani L, Miceli R, Fiore M, Lo Vullo S, Bertulli R, Collini P, Lozza L, Olmi P and Rosai J: Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: A series of patients treated at a single institution. J Clin Oncol. 23:96–104. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Jebsen NL, Trovik CS, Bauer HC, Rydholm A, Monge OR, Hall KS, Alvegård T and Bruland OS: Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: A Scandinavian sarcoma group study. Int J Radiat Oncol Biol Phys. 71:1196–1203. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Yang JC, Chang AE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, DeLaney T, Glatstein E, Steinberg SM, Merino MJ and Rosenberg SA: Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 16:197–203. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Koshy M, Rich SE and Mohiuddin MM: Improved survival with radiation therapy in high-grade soft tissue sarcomas of the extremities: A SEER Analysis. Int J Radiat Oncol Biol Phys. 77:203–209. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Davis AM, O'Sullivan B, Bell RS, Turcotte R, Catton CN, Wunder JS, Chabot P, Hammond A, Benk V, Isler M, et al: Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol. 20:4472–4477. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Pisters PWT, Pollock RE, Lewis VO, Yasko AW, Cormier JN, Respondek PM, Feig BW, Hunt KK, Lin PP, Zagars G, et al: Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg. 246:675–682. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Cahlon O, Brennan MF, Jia X, Qin LX, Singer S and Alektiar KM: A postoperative nomogram for local recurrence risk in extremity soft tissue sarcomas after limb-sparing surgery without adjuvant radiation. Ann Surg. 255:343–347. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Alektiar KM, Brennan MF, Healey JH and Singer S: Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity. J Clin Oncol. 26:3440–3444. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Folkert MR, Singer S, Brennan MF, Kuk D, Qin LX, Kobayashi WK, Crago AM and Alektiar KM: Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity. J Clin Oncol. 32:3236–3241. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang J, Wang S, Song Y, Liu X, Jin J, Wang W, Yu Z, Liu Y and Li Y: Postoperative intensity-modulated radiation therapy provides favorable local control and low toxicities in patients with soft tissue sarcomas in the extremities and trunk wall. Onco Targets Ther. 8:2843–2847. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Tran QNH, Kim AC, Gottschalk AR, Wara WM, Phillips TL, O'Donnell RJ, Weinberg V and Haas-Kogan DA: Clinical outcomes of intraoperative radiation therapy for extremity sarcomas. Sarcoma. 2006:916712006. View Article : Google Scholar : PubMed/NCBI | |
|
Call JA, Stafford SL, Petersen IA and Haddock MG: Use of intraoperative radiotherapy for upper-extremity soft-tissue sarcomas: Analysis of disease outcomes and toxicity. Am J Clin Oncol. 37:81–85. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Pellizzon ACA: Evidence and clinical outcomes of adult soft tissue sarcomas of the extremities treated with adjuvant high-dose-rate brachytherapy-a literature review. J Contemp Brachytherapy. 6:318–22. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Pisters PW, Harrison LB, Leung DH, Woodruff JM, Casper ES and Brennan MF: Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 14:859–868. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Tierney JF, Mosseri V, Stewart LA, Souhami RL and Parmar MK: Adjuvant chemotherapy for soft-tissue sarcoma: Review and meta-analysis of the published results of randomised clinical trials. Br J Cancer. 72:469–475. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A and Ghert M: A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 113:573–581. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Woll PJ, Reichardt P, Le Cesne A, Bonvalot S, Azzarelli A, Hoekstra HJ, Leahy M, Van Coevorden F, Verweij J, Hogendoorn PC, et al: Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): A multicentre randomised controlled trial. Lancet Oncol. 13:1045–1054. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Grobmyer SR, Maki RG, Demetri GD, Mazumdar M, Riedel E, Brennan MF and Singer S: Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Ann Oncol. 15:1667–1672. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Gronchi A, Frustaci S, Mercuri M, Martin J, Lopez-Pousa A, Verderio P, Mariani L, Valagussa P, Miceli R, Stacchiotti S, et al: Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: A randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group. J Clin Oncol. 30:850–856. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Frustaci S, Gherlinzoni F, De Paoli A, Bonetti M, Azzarelli A, Comandone A, Olmi P, Buonadonna A, Pignatti G, Barbieri E, et al: Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: Results of the Italian randomized cooperative trial. J Clin Oncol. 19:1238–1247. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Gronchi A, Verderio P, De Paoli A, Ferraro A, Tendero O, Majó J, Martin J, Comandone A, Grignani G, Pizzamiglio S, et al: Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall. Ann Oncol. 24:817–823. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wray CJ, Benjamin RS, Hunt KK, Cormier JN, Ross MI and Feig BW: Isolated limb perfusion for unresectable extremity sarcoma: Results of 2 single-institution phase 2 trials. Cancer. 117:3235–3241. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Eggermont AM and ten Hagen TL: Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: Credits, debits, and future perspectives. Curr Oncol Rep. 3:359–367. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Cheney MD, Giraud C, Goldberg SI, Rosenthal DI, Hornicek FJ, Choy E, Mullen JT, Chen YL and Delaney TF: MRI surveillance following treatment of extremity soft tissue sarcoma. J Surg Oncol. 109:593–596. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Rothermundt C, Whelan JS, Dileo P, Strauss SJ, Coleman J, Briggs TW, Haile SR and Seddon BM: What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients. Br J Cancer. 110:2420–2426. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Abatzoglou S, Turcotte RE, Adoubali A, Isler MH and Roberge D: Local recurrence after initial multidisciplinary management of soft tissue sarcoma: Is there a way out? Clin Orthop Relat Res. 468:3012–3018. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Potter DA, Glenn J, Kinsella T, Glatstein E, Lack EE, Restrepo C, White DE, Seipp CA, Wesley R and Rosenberg SA: Patterns of recurrence in patients with high-grade soft-tissue sarcomas. J Clin Oncol. 3:353–366. 1985. View Article : Google Scholar : PubMed/NCBI | |
|
Marulli G, Mammana M, Comacchio G and Rea F: Survival and prognostic factors following pulmonary metastasectomy for sarcoma. J Thorac Dis. 9 (Suppl 12):S1305–S1315. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Smith R, Pak Y, Kraybill W and Kane JM III: Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy. Eur J Surg Oncol. 35:356–3561. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Borden EC, Amato DA, Rosenbaum C, Enterline HT, Shiraki MJ, Creech RH, Lerner HJ and Carbone PP: Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas. J Clin Oncol. 5:840–850. 1987. View Article : Google Scholar : PubMed/NCBI | |
|
Edmonson JH, Ryan LM, Blum RH, Brooks JS, Shiraki M, Frytak S, Frytak S and Parkinson DR: Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol. 11:1269–1275. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Antman K, Crowley J, Balcerzak SP, Rivkin SE, Weiss GR, Elias A, Natale RB, Cooper RM, Barlogie B, Trump DL, et al: An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol. 11:1276–1285. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Judson I, Verweij J, Gelderblom H, Hartmann JT, Schöffski P, Blay JY, Kerst JM, Sufliarsky J, Whelan J, Hohenberger P, et al: Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: A randomised controlled phase 3 trial. Lancet Oncol. 15:415–423. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lilly Reports Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO®, . https://lilly.mediaroom.com/index.php?s=9042&item=137861January 18–2019 | |
|
Frezza AM, Stacchiotti S and Gronchi A: Systemic treatment in advanced soft tissue sarcoma: What is standard, what is new. BMC Med. 15:1092017. View Article : Google Scholar : PubMed/NCBI | |
|
Demetri GD, Von Mehren M, Jones RL, Hensley ML, Schuetze SM, Staddon A, Milhem M, Elias A, Ganjoo K, Tawbi H, et al: Efficacy and safety of trabectedin or dacarbazine for metastatic liposarcoma or leiomyosarcoma after failure of conventional chemotherapy: Results of a phase III randomized multicenter clinical trial. J Clin Oncol. 34:786–793. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Maki RG, Wathen JK, Patel SR, Priebat DA, Okuno SH, Samuels B, Fanucchi M, Harmon DC, Schuetze SM, Reinke D, et al: Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: Results of sarcoma alliance for research through collaboration study 002 [corrected]. J Clin Oncol. 25:2755–2763. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
García-del-Muro X, López-Pousa A, Maurel J, Martín J, Martínez-Trufero J, Casado A, Gómez-España A, Fra J, Cruz J, Poveda A, et al: Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: A Spanish group for research on sarcomas study. J Clin Oncol. 29:2528–2533. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Van Der Graaf WT, Blay JY, Chawla SP, Kim DW, Bui-Nguyen B, Casali PG, Schöffski P, Aglietta M, Staddon AP, Beppu Y, et al: Pazopanib for metastatic soft-tissue sarcoma (PALETTE): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 379:1879–1886. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Young RJ, Litière S, Lia M, Hogendoorn PCW, Fisher C, Mechtersheimer G, Daugaard S, Sciot R, Collin F, Messiou C, et al: Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: A subgroup analysis of the European Organisation for research and treatment of cancer 62012 study. Acta Oncol. 56:1013–1020. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Gronchi A, Ferrari S, Quagliuolo V, Broto JM, Pousa AL, Grignani G, Basso U, Blay JY, Tendero O, Beveridge RD, et al: Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): An international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol. 18:812–822. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Tawbi HA, Burgess M, Bolejack V, Van Tine BA, Schuetze SM, Hu J, D'Angelo S, Attia S, Riedel RF, Priebat DA, et al: Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): A multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet Oncol. 18:1493–1501. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Lee SH, Chang MH, Baek KK, Han B, Lim T, Lee J and Park JO: High-dose ifosfamide as second- or third-line chemotherapy in refractory bone and soft tissue sarcoma patients. Oncology. 80:257–261. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Kawai A, Araki N, Sugiura H, Ueda T, Yonemoto T, Takahashi M, Morioka H, Hiraga H, Hiruma T, Kunisada T, et al: Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: A randomised, open-label, phase 2 study. Lancet Oncol. 16:406–416. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
de Necochea-Campion R, Zuckerman LM, Mirshahidi HR, Khosrowpour S, Chen CS and Mirshahidi S: Metastatic biomarkers in synovial sarcoma. Biomark Res. 5:42017. View Article : Google Scholar : PubMed/NCBI | |
|
Kadoch C and Crabtree GR: Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma. Cell. 153:71–85. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Agulnik M, Tannir NM, Pressey JG, Gounder MM, Cote GM, Roche M, Doleman S, Blakemore SJ, Clawson A, Daigle S, et al: A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adult subjects with INI1-negative tumors or relapsed/refractory synovial sarcoma. J Clin Oncol. 34:110712016. View Article : Google Scholar | |
|
Pink D, Richter S, Gerdes S, Andreou D, Tunn PU, Busemann C, Ehninger G, Reichardt P and Schuler MK: Gemcitabine and docetaxel for epithelioid sarcoma: Results from a retrospective, multi-institutional analysis. Oncology. 87:95–103. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Grivas A, Trafalis DT, Thanopoulou E, Ziras NG and Athanasiou AE: Treatment with trabectedin: Should be indicated to all soft tissue sarcoma histotypes? J BUON. 15:791–793. 2010.PubMed/NCBI | |
|
Cornillie J, van Cann T, Wozniak A, Hompes D and Schöffski P: Biology and management of clear cell sarcoma: State of the art and future perspectives. Expert Rev Anticancer Ther. 16:839–845. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Wagner AJ, Goldberg JM, Dubois SG, Choy E, Lee R, Pappo A, Geller J, Judson I, Hogg D, Senzer N, et al: Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: Results of a multicenter phase 2 trial. Cancer. 118:5894–5902. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Schöffski P, Adkins D, Blay JY, Gil T, Elias AD, Rutkowski P, Pennock GK, Youssoufian H, Gelderblom H, Willey R and Grebennik DO: An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours. Eur J Cancer. 49:3219–3228. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Goldberg JM, Fisher DE, Demetri GD, Neuberg D, Allsop SA, Fonseca C, Nakazaki Y, Nemer D, Raut CP, George S, et al: Biologic activity of autologous, granulocyte-macrophage colony-stimulating factor secreting alveolar soft-part sarcoma and clear cell sarcoma vaccines. Clin Cancer Res. 21:3178–3186. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
O'Sullivan B, Davis AM, Turcotte R, Bell R, Catton C, Chabot P, Wunder J, Kandel R, Goddard K, Sadura A, et al: Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: A randomised trial. Lancet. 359:2235–2241. 2002. View Article : Google Scholar : PubMed/NCBI |
